The U.S. Food and Drug Administration has awarded nine companies priority review vouchers under its new Commissioner’s ...
Artiva Biotherapeutics skyrocketed today after receiving FDA Fast Track status for its AlloNK therapy in refractory rheumatoid arthritis.
The FDA has named the first nine medications selected for its national priority review voucher program, which aims to shorten drug review timelines to ...
NATIONAL CITY, Calif. and DOWNERS GROVE, Ill., Oct. 17, 2025 (GLOBE NEWSWIRE) -- Future technology professionals can get a jump start on their ...
The US Food and Drug Administration on Thursday announced the first drug manufacturers that will receive expedited reviews as part of a new initiative to reward companies for acquiescing to the Trump ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback